Abstract: BACKGROUND: Post-viral secondary bacterial infections, such as those caused by Streptococcus pneumoniae, are strongly associated with influenza and respiratory syncytial …
Abstract: BACKGROUND: Chronic hepatitis C virus (HCV) infection affects >1% of the US population and a larger percentage of US veterans. Direct-acting antiviral (DAA) medications …
Abstract: Background: Nirmatrelvir-ritonavir is recommended for persons at risk for severe coronavirus disease 2019 (COVID-19) but remains underutilized. Information on which …
Abstract: BACKGROUND: Estimated hepatitis C prevalence within the Veterans Health Administration is higher than the general population and is a risk factor for advanced liver …
Abstract: Timely antiviral therapy is critical in chronic hepatitis B (CHB) cirrhosis, to prevent further liver complications. Among a national cohort of US Veterans with CHB …
Abstract: OBJECTIVES: Molnupiravir and nirmatrelvir-ritonavir were the first oral antiviral agents to demonstrate reduced hospitalization or death in patients with severe acute …
Abstract: Background Persons with human immunodeficiency virus (HIV, PWH) are at increasingly higher risk for metabolic complications, including diabetes mellitus (DM). …